Efficacy of omalizumab in eosinophilic chronic rhinosinusitis patients with asthma

Ann Allergy Asthma Immunol. 2013 May;110(5):387-8. doi: 10.1016/j.anai.2013.01.024. Epub 2013 Feb 23.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Aged
  • Anti-Allergic Agents / therapeutic use*
  • Anti-Asthmatic Agents / therapeutic use
  • Antibodies, Anti-Idiotypic / therapeutic use*
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Asthma / drug therapy
  • Asthma / immunology
  • Asthma / pathology
  • Eosinophilia / drug therapy*
  • Eosinophilia / immunology
  • Eosinophilia / pathology
  • Female
  • Humans
  • Leukocyte Count
  • Male
  • Middle Aged
  • Omalizumab
  • Rhinitis / drug therapy*
  • Rhinitis / immunology
  • Rhinitis / pathology
  • Sinusitis / drug therapy*
  • Sinusitis / immunology
  • Sinusitis / pathology

Substances

  • Anti-Allergic Agents
  • Anti-Asthmatic Agents
  • Antibodies, Anti-Idiotypic
  • Antibodies, Monoclonal, Humanized
  • Omalizumab